Given the fact that STAT2-dependent signaling mediates a highly conserved biological response in humans and mice, it is conceivable that our results might represent a solid basis for translational approaches focused on targeting this pathway in patients with CRC. This evidence concerns the gene STAT2 and colorectal carcinoma.